REATA PHARMACEUTICALS INC's ticker is and the CUSIP is 75615P903. A total of 5 filers reported holding REATA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $8,972,480 | +1.3% | 88,000 | -9.7% | 0.00% | -25.0% |
Q1 2023 | $8,855,608 | +649.5% | 97,400 | +213.2% | 0.00% | +300.0% |
Q4 2022 | $1,181,489 | -87.1% | 31,100 | -91.4% | 0.00% | -75.0% |
Q3 2022 | $9,140,000 | +1526.3% | 363,700 | +1865.9% | 0.00% | – |
Q2 2022 | $562,000 | – | 18,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 12,300 | $988,000 | 0.55% |
BOOTHBAY FUND MANAGEMENT, LLC | 87 | $699,000 | 0.06% |
SIMPLEX TRADING, LLC | 157 | $1,260,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GROUP ONE TRADING, L.P. | 400 | $32,000 | 0.00% |